Over-reliance in cardiovascular treatment – a supply risk that needs to change
New Zealand’s reliance on the cardiovascular medicines metoprolol succinate and cilazapril is out of step with other countries, writes Dr Richard Medlicott, Medical Director of the Royal New Zealand College of General Practitioners.
Treating hepatitis C in New Zealand
General practice has a real opportunity to significantly lead the way to treat people in the community with the medicines we fund for hepatitis C, but we still have some way to go, writes Dr Bryan Betty, GP and PHARMAC Deputy Medical Director.
Newsletters
Device Advice: Your update on PHARMAC’s Hospital Medical Devices programme.
Hospital News: News about getting the best value for what we spend on hospital pharmaceuticals.
Inpharmation: News about PHARMAC's activities and pharmaceutical-related issues.
Inpharmation in Hospitals: Hospital news about PHARMAC's activities and pharmaceutical-related issues.
Te Whaioranga ePānui: A PHARMAC newsletter for people with an interest in Māori health.
(external link) 
(external link)
Media queries
For media queries, contact:
